We are live on ! Find out more
NVNO

enVVeno Medical
NVNO

31 hedge funds and large institutions have $19.8M invested in enVVeno Medical in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,965% more call options, than puts

Call options by funds: $4.11M | Put options by funds: $199K

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

11% more funds holding

Funds holding: 28 → 31 (+3)

0.14% less ownership

Funds ownership: 0.92% → 0.78% (-0.14%)

11% less capital invested

Capital invested by funds: $22.2M → $19.8M (-$2.33M)

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
8
Reduced
7
Closed
8
Calls
$4.11M
Puts
$199K
Net Calls
+$3.91M
Net Calls Change
+$1.31M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.22M
2
ACM
ADAR1 Capital Management
Texas
+$1.03M
3
RAG
RIA Advisory Group
Iowa
+$224K
4
KCM
Kingdon Capital Management
New York
+$178K
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$175K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.24M
2
ACM
Altium Capital Management
New York
-$1.77M
3
RA
Rosalind Advisors
Ontario, Canada
-$1.6M
4
NCM
Nantahala Capital Management
Connecticut
-$1.08M
5
Morgan Stanley
Morgan Stanley
New York
-$121K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$37K +$35K +195 New
UBS Group
27
UBS Group
Switzerland
$30.2K +$28.5K +159 New
WIM
28
Westside Investment Management
California
$20.4K +$19.2K +107 New
TRCT
29
Tower Research Capital (TRC)
New York
$19K +$3.41K +19 +23%
Wells Fargo
30
Wells Fargo
California
$11.4K – – –
CIBC Private Wealth Group
31
CIBC Private Wealth Group
Georgia
$4.53K +$4.49K +25 New
AC
32
Armistice Capital
New York
– -$2.24M -12,457 Closed
ACM
33
Altium Capital Management
New York
– -$1.77M -9,842 Closed
RA
34
Rosalind Advisors
Ontario, Canada
– -$1.6M -8,917 Closed
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
– -$95.6K -533 Closed
AMCA
36
Arthur M. Cohen & Associates
Illinois
– -$72K -400 Closed
XT
37
XTX Topco
Cayman Islands
– -$58K -323 Closed
FP
38
Financial Perspectives
Minnesota
– -$16.8K -94 Closed
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
– -$538 -3 Closed
Bank of America
40
Bank of America
North Carolina
– -$41 – –
1
2

NVNO Hedge Fund Activity: Q1 2024 in Review

31 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q1 2024, worth a combined $19.8M — down 11% from $22.2M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NVNO positions and 8 closed out — a net gain of 3 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.22M. The largest seller was Armistice Capital, exiting entirely with an estimated $2.24M sold.

  • 31 institutional investors held enVVeno Medical (NVNO) as of Q1 2024, up from 28 in Q4 2023.
  • Funds reported $19.8M of enVVeno Medical stock for Q1 2024, down 11% quarter-over-quarter.
  • 11 funds opened new enVVeno Medical positions in Q1 2024 and 8 closed out, a net change of +3 holders.
  • The largest enVVeno Medical buyer in Q1 2024 was Vanguard Group, an estimated $1.22M added.
  • The largest enVVeno Medical seller in Q1 2024 was Armistice Capital, an estimated $2.24M sold.

Based on aggregated 13F filings for Q1 2024.